Drug Topics
APRIL 12, 2024
Although over 38 million people in the US have diabetes, continuous glucose monitor (CGM) uptake is low. Community pharmacists are uniquely positioned to promote uptake due to their frequent interactions with patients and expertise in chronic condition counseling.
STAT
APRIL 12, 2024
The recent detection of H5N1 bird flu in U.S. cattle, coupled with reports of a dairy worker contracting the virus , demands a departure from the usual reassurances offered by federal health officials. While they emphasize there’s no cause for alarm and assert diligent monitoring, it’s imperative we break from this familiar script. H5N1, a strain of the flu virus known to infect bird species globally and several mammalian species in the U.S. since 2022, has now appeared to have bre
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
APRIL 12, 2024
Since a 2019 measles outbreak, the CDC has seen an increasing number of cases in the US.
STAT
APRIL 12, 2024
In the final year of World War II, Nazi troops starved the Netherlands in a brutal event known as the Dutch Hunger Winter. Some 20,000 people died and millions more suffered from this man-made famine. The survivors went on to have children and even grandchildren with increased rates of metabolic issues like diabetes, hypertension, and schizophrenia.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
APRIL 12, 2024
After a long hiatus, research in psychedelic medicine is progressing rapidly. With the potential approval of MDMA in the near future, what role will pharmacists play in integrating these new therapies into treatment plans?
STAT
APRIL 12, 2024
Amid the many demands of practicing medicine, doctors can have less time and energy for their patients, and those relationships can suffer. Yet research has shown that when physicians show empathy, that can generally lead to better clinical outcomes, at least over the near-term. Now, a new study, published Thursday in JAMA Network Open , demonstrates that those benefits can extend longer and be even more effective than some clinical therapies in dealing with lower back pain, which affects half o
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
APRIL 12, 2024
Physicians made steady pay gains last year, as total compensation grew by a modest 3%, increasing from an average of $352,000 to $363,000. | Any contentment about compensation gains was undercut by the effects of high inflation rates throughout 2023 and Medicare reimbursement cuts, according to Medscape's 2024 physician compensation report.
Drug Topics
APRIL 12, 2024
Test your pharmacy news knowledge with our weekly quiz.
Pharmacy Times
APRIL 12, 2024
Jonathan Levitt, Esq, discusses legislation and legal action taken to rein in pharmacy benefit managers’ DIR fees.
Fierce Healthcare
APRIL 12, 2024
A year ago, Blue Shield of California joined forces with Accolade and TeleMed2U to launch Virtual Blue, a new plan that centers on virtual care for members with the goal of boosting access. | A year ago, Blue Shield of California joined forces with Accolade and TeleMed2U to launch Virtual Blue, a new plan that centers on virtual care for members with the goal of boosting access.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
APRIL 12, 2024
LONDON — Following a nine-month investigation, European regulators said Friday they have found no evidence that GLP-1 drugs like Ozempic and Wegovy cause suicidal thoughts or actions. The announcement from the European Medicines Agency echoes the findings of a review by the U.S. Food and Drug Administration, which in January said it did not find a causal relationship between the class of weight loss and diabetes medications and suicidal ideation.
Fierce Healthcare
APRIL 12, 2024
Nearly all hospitals’ websites collect and transmit user information to third parties, yet most do not have privacy policies that tell the visitors who exactly will be receiving those data, accordi | A recent study warns that many hospitals' user tracking and disclosure practices could open their organizations up to lawsuits.
Pharmacy Times
APRIL 12, 2024
In addition to emerging treatment options, the speakers addressed the importance of individualized decision-making when treating patients with multiple myeloma.
pharmaphorum
APRIL 12, 2024
Stay up to date on the latest agency, consultancy, and investor hires from March 2024 with Changing Faces. Learn about Langland, 4BIO Capital, Jeito Capital and more.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
APRIL 12, 2024
In addition to oral administration, patients with partial-onset seizures can now take the antiseizure medication via a nasogastric tube if the tablet is crushed and mixed with water.
STAT
APRIL 12, 2024
In response to controversy, a group of Colorado lawmakers is abandoning a bill that would have required a new state board — which is chartered with setting caps for the cost of medicines — to create exemptions for rare disease drugs. Instead, the lawmakers introduced a watered-down version to require the Prescription Drug Affordability Board to consider different uses of any medicine with a so-called orphan designation, which refers to treatments for rare diseases.
pharmaphorum
APRIL 12, 2024
Uncover the importance of adaptive EDI strategies in the UK through research and discussions on diversity. Explore the benefits and best practices in promoting a more inclusive workplace.
Fierce Pharma
APRIL 12, 2024
Merck CEO Robert Davis has cracked the $20-million mark in annual pay for the first time, putting him in an exclusive club of biopharma heavy hitters. | Merck CEO Robert Davis has cracked the $20-million mark in annual pay for the first time, putting him in an exclusive club of biopharma heavy hitters. Davis, 57, received a 9% bump in pay in 2023 to $20.3 million, according to the company’s proxy filing.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
APRIL 12, 2024
If a preventable error that might cause harm occurs during medical care, should there be transparency, or should the incident be swept under the rug? A rule proposed by the U.S. Nuclear Regulatory Commission (NRC) leans toward the latter. We believe that transparency is best: patients need it so they know what happens to them during their care; clinicians need it so they can mitigate harm and prevent future errors.
Fierce Pharma
APRIL 12, 2024
History is repeating for AstraZeneca CEO Pascal Soriot, who successfully dodged an executive pay revolt at the company’s annual meeting Thursday, echoing a similar situation that played out in 2021 | Out of more than 1.18 billion votes cast by AstraZeneca shareholders at the company's annual meeting this week, 64.43% of investors voted in favor of an updated pay policy that could see CEO Pascal Soriot earn upward of 18.7 million pounds sterling ($23.5 million) for his performance this year.
The Checkup by Singlecare
APRIL 12, 2024
Seasonal allergies can turn a perfect spring or summer day into a sneeze-fest. Uncomfortable allergy symptoms—such as itchy eyes, runny nose, or nasal congestion—often disrupt sleep, affect concentration, and impact overall quality of life. Also called hay fever or seasonal allergic rhinitis, seasonal allergies are typically caused by airborne allergens like mold spores, pollen, grasses, and weeds.
Fierce Pharma
APRIL 12, 2024
After oncology experts reviewed arguments in favor of a surrogate endpoint to support multiple myeloma drug approvals, drug developers may soon have a new pathway in the R&D journey. | After oncology experts reviewed arguments in favor of a surrogate endpoint to support multiple myeloma drug approvals, drug developers may soon have a new pathway in the R&D journey.
Pharmacy Times
APRIL 12, 2024
Treatment with LYT-200 is currently being assessed in a phase 1/2 adaptive design trial in advanced/metastatic solid tumors and in a phase 1b clinical trial.
pharmaphorum
APRIL 12, 2024
BioMarin’s Voxzogo has been shown to increase growth rates in children with hypochondroplasia, a genetic cause of very short stature, in a phase 2 trial
The Checkup by Singlecare
APRIL 12, 2024
Looking for an Ozempic shortage update? You’re not alone. The short supply of this Type 2 diabetes drug has been the subject of many headlines and social media posts. But the Ozempic shortage is not the first of its kind. Drug shortages happen from time to time. For patients impacted by this issue, it’s important to understand current supply and demand and learn how to prepare for any future Ozempic shortage.
pharmaphorum
APRIL 12, 2024
Our regular round-up of financings in the biotech sector features rounds for TORL BioTherapeutics, Nvelop Therapeutics, D3 Bio, and Century Therapeutics.
European Pharmaceutical Review
APRIL 12, 2024
There has been a “notable” rise in licensing agreements for innovator drugs incorporating clustered regularly interspaced short palindromic repeats (CRISPR)-based technology for gene therapies over the past five years, according to data and analytics firm GlobalData. These agreements have amassed a total deal value of $21 billion. Of note, between 2020 to 2022, there was a “remarkable surge” in deal worth.
pharmaphorum
APRIL 12, 2024
To mark World Parkinson’s Day, former broadcaster Jeremy Paxman has delivered a list of recommendations for improving how the disease is managed in the UK to Prime Minister Rishi Sunak.
Pharmaceutical Commerce
APRIL 12, 2024
The latest news for pharma industry insiders.
pharmaphorum
APRIL 12, 2024
Shareholders in AstraZeneca have voted to approve controversial increase in the salary and bonus package for CEO Pascal Soriot.
The Checkup by Singlecare
APRIL 12, 2024
Wegovy is an injectable prescription medication approved by the Food and Drug Administration (FDA) for treating obesity. It is intended to be taken weekly in conjunction with diet and exercise to help people lose weight. Its active ingredient, semaglutide, is a glucagon-like peptide-1 (GLP-1) agonist. People see as high as 14.9% total body weight loss with Wegovy, according to clinical trials published in the New England Journal of Medicine.
Pharmaceutical Technology
APRIL 12, 2024
Moderna has announced the halt of its project to build a messenger ribonucleic acid (mRNA) manufacturing facility in Kenya.
PharmaVoice
APRIL 12, 2024
Why these clinical setbacks impacted the companies, industry and patients.
Expert insights. Personalized for you.
212 
Let's personalize your content